# FDA 483 - Kimball A. Johnson, M.D. - May 21, 2026

Source: https://www.keypedia.com/records/483/kimball-a-johnson-md/2fee35ce-c2f8-49e1-ad87-e59e618a1b27

> FDA 483 for Kimball A. Johnson, M.D. on May 21, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kimball A. Johnson, M.D.
- Inspection Date: 2026-05-21
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Kimball A. Johnson, M.D. in Decatur, GA, a clinical investigator, revealed a significant protocol deviation. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan, resulting in three out of four enrolled subjects receiving investigational product doses exceeding protocol-allowed limits and experiencing adverse events.

## Related Officers

- [Brandy D. Brown](https://www.keypedia.com/people/brandy-d-brown/667c6b9a-6ab9-42d4-b364-a96207bca072)
- [Peyton L. Sloan](https://www.keypedia.com/people/peyton-l-sloan/87edf6eb-bf9d-4662-ac2b-b3c291f4ea9f)

Company: https://www.keypedia.com/companies/kimball-a-johnson-md/ee151a27-f4a7-44c5-84c5-df2f8fe5cca4

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7